We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · March 13, 2018

Psoriasis Patients on TNF-α Inhibitors Have Lower Cardiovascular Risk Than Those Receiving Phototherapy

Journal of the American Academy of Dermatology


Additional Info

Journal of the American Academy of Dermatology
The Risk of Cardiovascular Events in Psoriasis Patients Treated With Tumor Necrosis Factor-Alpha Inhibitors Versus Phototherapy: An Observational Cohort Study
J Am Acad Dermatol 2018 Feb 27;[EPub Ahead of Print], JJ Wu, M Sundaram, M Cloutier, M Gauthier-Loiselle, A Guérin, R Singh, A Ganguli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading